or Try an Advanced Search...

    Stage Biotechnology Stocks List

    Symbol Grade Name % Change
    ALLO F Allogene Therapeutics, Inc. -7.97
    BOLD D Boundless Bio, Inc. -2.91
    CELC D Celcuity Inc. -5.10
    CELU F Celularity Inc. -1.64
    COCP C Cocrystal Pharma, Inc. -0.76
    GANX F Gain Therapeutics, Inc. -2.23
    GLYC F GlycoMimetics, Inc. 6.51
    IMNN C Imunon, Inc. 0.00
    KA F Kineta, Inc. -7.19
    LGVN F Longeveron Inc. -0.78
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates Diagnostics & Research
    Related Stock Lists: Biotechnology Cancer Life Sciences Biology Virus Allosteric Regulation Antiviral Drug Applied Genetics Autoimmune And Inflammatory Disease Autoimmunity Benign Prostatic Hyperplasia Biocides Biomolecules Bph Cell Biology Cell Encapsulation Cell Signaling Complement System Coronavirus Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Stage Biotechnology stocks.

    Symbol Grade Name Weight
    PTH C Invesco DWA Healthcare Momentum ETF 2.74
    BBC D Virtus LifeSci Biotech Clinical Trials ETF 2.27
    SBIO C ALPS Medical Breakthroughs ETF 1.48
    DWAS B PowerShares DWA SmallCap Technical Leaders Portfolio 1.36
    JFWD C Jacob Funds Inc. Jacob Forward ETF 0.97
    View all Stage Biotechnology ETFs...
    Compare ETFs
    Compare BBC to JFWD Compare DWAS to JFWD Compare PTH to SBIO

        Stage Biotechnology Stocks Recent News

        Date Stock Title
        May 16 COCP COCP: Enrollment Complete in Phase 2a Human Challenge Trial of CC-42344…
        May 16 CELC Celcuity Inc (CELC) (Q1 2024) Earnings Call Transcript Highlights: Navigating Challenges and ...
        May 15 CELC Celcuity Inc. (CELC) Q1 2024 Earnings Call Transcript
        May 15 KA Kineta GAAP EPS of -$0.89
        May 15 CELC Celcuity Non-GAAP EPS of -$0.59
        May 15 CELC Celcuity Inc. Reports First Quarter Financial Results and Provides Corporate Update
        May 15 KA Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial and Corporate Activities
        May 15 LGVN Longeveron GAAP EPS of -$1.61 beats by $0.39, revenue of $0.55M beats by $0.49M
        May 15 ALLO Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
        May 15 LGVN LGVN Making Great Strides
        May 14 LGVN Longeveron Announces First Quarter 2024 Financial Results and Provides Business Update
        May 14 ALLO Allogene (ALLO) Q1 Earnings in Line With Estimates, Sales Lag
        May 14 CELU Celularity Data Published in Journal for ImmunoTherapy of Cancer Reveals Benefits of Placental Circulating T Cells for CAR-T Therapy
        May 14 GANX Gain Therapeutics GAAP EPS of -$0.22
        May 14 GANX Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
        May 14 ALLO Allogene Therapeutics Inc (ALLO) (Q1 2024) Earnings Call Transcript Highlights: Strategic ...
        May 13 ALLO Allogene Therapeutics, Inc. (ALLO) Q1 2024 Earnings Call Transcript
        May 13 ALLO Allogene Therapeutics (ALLO) Reports Q1 Loss, Lags Revenue Estimates
        May 13 ALLO Allogene Therapeutics announces pricing of $110M offering of common stock
        May 13 ALLO Allogene Therapeutics Announces Pricing of $110 million Offering of Common Stock
        Related Industries: Biotechnology Conglomerates Diagnostics & Research
        Related Stock Lists: Biotechnology Cancer Life Sciences Biology Virus Allosteric Regulation Antiviral Drug Applied Genetics Autoimmune And Inflammatory Disease Autoimmunity Benign Prostatic Hyperplasia Biocides Biomolecules Bph Cell Biology Cell Encapsulation Cell Signaling Complement System Coronavirus Diabetes
        Stage Biotechnology

        Browse All Tags